The USF College of Nursing is pleased to host Ellen M. Lavoie Smith, PhD, APRN, AOCN®, FAAN, who will present “Bedside to Bench to Bedside: Managing Painful Chemotherapy-Induced Peripheral Neuropathy” at noon on Tuesday, March 5, in MDN 2005.
Dr. Smith is an associate professor and director of the PhD program at the University of Michigan School of Nursing. Her program of research is focused on improving the assessment and treatment of chronic, cancer-related neuropathic pain, with a specialty focus in painful chemotherapy-induced peripheral neuropathy.
She has received independent research funding from the National Institutes of Health, the Oncology Nursing Society, the American Cancer Society, Dartmouth, and the University of Michigan. Dr. Smith conducted a cross-sectional study evaluating the clinimetric properties of peripheral neuropathy and neuropathic pain measurement approaches. She also completed an Oncology Nursing Society-funded study focused on utilizing quality improvement methodology to improve neuropathic pain management in cancer patients.
Dr. Smith recently completed a national multisite research trial through the Cancer and Leukemia Group B (CALGB 170601). This was the first large randomized, placebo-controlled trial to reveal an effective intervention (duloxetine) for painful chemotherapy-induced peripheral neuropathy.
Her findings on the “Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy” were featured in the JAMA Report (April 3, 2013). In addition, a television clip highlighting this study was aired on 183 television stations throughout the United States and was viewed by more than 17 million viewers, with another 82 million viewing the video clip online. It was also covered in a video segment by Sanjay Gupta, MD.
Dr. Cheedy Jaja is an associate professor in the College of Nursing at the University of South Carolina in Columbia and a board-certified Psychiatric and Mental Health Nurse Practitioner. His eclectic education includes graduate degrees in public administration and policy, public health genetics, philosophy, political science, and clinical and translational science. He was the inaugural Pharmacogenetics, Ethics, and Public Policy Postdoctoral Fellow at the Indiana University School of Medicine. His research interests are sickle cell disease pain, analgesic, and psychopharmacogenetics. He has over 14 years of experience providing clinical and psychosocial care primarily to sickle cell disease patients in ambulatory healthcare settings locally and internationally.
Dr. Jaja is actively involved in global health. During the Ebola virus disease epidemic in 2014-2015, he served two tours of duty in Sierra Leone with the Boston-based humanitarian organization, Partners in Health. More recently, in the West African nation of Sierra Leone, he was instrumental in establishing a pediatric sickle cell disease clinic.
Currently, Dr. Jaja holds leadership positions in organizations including the International Association of Sickle Cell Nurses and Physician Assistants and the Network of Minority Research Investigators and has received a Fulbright Scholar Fellowship award from the U.S. State Department, among other honors. In 2020, he was inducted into the American Academy of Nursing.
Learning Objective: As a result of participating in this activity, the learner will be able to review and critically appraise evidence-based teaching strategies and to discuss implications of these strategies for clinical practice, classroom teaching, and online teaching.
Target Audience: APRNs and Registered Nurses who are not APRNs; Physicians and/or PAs.
Competencies to be addressed: Patient Care and Procedural Skills; Systems-based Practice; Medical Knowledge; Interpersonal and Communication Skills; Professionalism
Fees: There are no fees and no prerequisites for this activity.
To receive credit, participants MUST sign in for each session they attend. Those participants who DO NOT sign in will NOT receive credit for the session.